2026 HMTRC Workshop

2026 Workshop Video Presentations

Welcome & Introductions: Dr. Dan Vigneron PhD, HMTRC Director & Dr. Christopher Hess MD, PhD, Chair of Radiology & Biomedical Imaging
Hyperpolarized C-13 MRI Clinical Translation - Progress and Opportunities Dr. Zhen Jane Wang MD, HP Medical Director
TR&D1: Technology Development for Polarizer and Detector Instrumentation: Drs. Dan Vigneron PhD & Jeremy Gordon PhD & Duy Dang PharmD
TR&D2: Development of Novel Hyperpolarized (HP) MR Molecular Imaging Probes Tested in Realistic Preclinical Models and Correlative Science Studies: Drs. Renuka Sriram PhD & John Kurhanewicz PhD
TR&D3: Acquisition and Analysis Methods for Hyperpolarized MR Data: Drs. Duan Xu PhD & Peder Larson PhD

Dr. James Bankson PhD & Stephen Lai MDexternal site (opens in a new window), UT MD Anderson Cancer Center: HP C-13 at UT MD Anderson Cancer Center
Dr. Shonit Punwani MD, PhD, University College London: Ignore, Control or Calibrate?
Dr. Kayvan Keshari PhD, Memorial Sloan Kettering Cancer Center, NY: The False of Ornithine Metabolism in Prostate Cancer
Dr. Jae Mo Park PhD, University of Texas Southwestern Medical Center: Lactate as a Window into Pyruvate Metabolism in the Brain
Dr. Mathilde Hauge Lerche PhD, Technical University of Denmark: Extending Hyperpolarized MRI Beyond Fast Metabolism using 15N,d9-Betaine
Dr. Jay Ying-Chieh Lai PhDexternal site (opens in a new window), Chang Gung Memorial Hospital, Taiwan: Hyperpolarized C-13 MRI for Immune Response Prediction in Patients with Hepatocellular Carcinoma (HCC)Undergoing Proton Beam Therapy,Atezolizumab, and Bevacizumab (PBTAB)
Dr. Chuck Cunningham PhDexternal site (opens in a new window), University of Toronto: Human Brain Imaging with HP C-13 MRI
Dr. Charlie Khemtong PhDexternal site (opens in a new window), University of Florida: Investigating Hepatic Metabolism in Alpha-1 Antitrypsin Deficient Mice

Dr. Calvin Chin MD, PhDexternal site (opens in a new window), National Heart Centre Singapore: Hyperpolarized Imaging in Diabetic Kidney Disease
Dr. Yan Li MD PhDexternal site (opens in a new window), UCSF: Hyperpolarized ¹³C MRI in Gliomas: Assessing Tumor Metabolism for Clinical Evaluation
Dr. Joshua Kaggie PhDexternal site (opens in a new window), University of Cambridge: Imaging Metabolism and Beyond
Dr. Dan Crooks MS PhDexternal site (opens in a new window), NIH/NCI: Targeting Tumor Oxygen and Glycolysis using NQO1-activated Pro-drugs
Dr. Robert Bok MD, PhDexternal site (opens in a new window), UCSF: Overview of Clinically-Focused HP ¹³C-MRI Prostate Cancer Imaging Studies at UCSF
Dr. Maria Roselle Abraham MDexternal site (opens in a new window), UCSF: Hyperpolarized ¹³C-pyruvate MRI for Cardiac Metabolic Phenotyping
Dr. Kazu Yamamoto PhDexternal site (opens in a new window), NIH/NCI: Clinical Hyperpolarized ¹³C Metabolic MRI at NCI

Dr. Matthew Merritt PhD, University of Florida: Dysfunctional Pyruvate Carboxylase Flux in T1D Mouse Models
Dr. Stephan Gloggler PhD,external site (opens in a new window) University of Texas Southwestern Medical Center: Exploring New Hyperpolarization Frontiers in High and Low Magnetic Fields with Parahydrogen
Dr. Tom Jue PhDexternal site (opens in a new window), UC Davis: Reciprocal Interaction of Alzheimer’s Disease and Diabetes
Dr. Pavithra Viswanath PhDexternal site (opens in a new window), UCSF: Lactylation Fuels Nucleotide Biosynthesis and Facilitates Deuterium Metabolic Imaging of Tumor Proliferation in H3K27M-mutant Gliomas
Dr. Vicent Ribas PhDexternal site (opens in a new window), IBEC, Barcelona, Spain: Investigating the Impact of Obesity on Liver Metabolism Using Hyperpolarized MRSI
Dr. Tamara Vasilkovska MD, PhDexternal site (opens in a new window), UCSF: Hyperpolarized ¹³C MRI of Metabolic Dysfunction in Alzheimer’s Disease: From Detection to Modulation
Dr. Jeff Brender PhDexternal site (opens in a new window), NIH/NCI: Clinical Reality of HP MRI